Engineering the yeast <it>Yarrowia lipolytica</it> for the production of therapeutic proteins homogeneously glycosylated with Man<sub>8</sub>GlcNAc<sub>2</sub> and Man<sub>5</sub>GlcNAc<sub>2</sub>
<p>Abstract</p> <p>Background</p> <p>Protein-based therapeutics represent the fastest growing class of compounds in the pharmaceutical industry. This has created an increasing demand for powerful expression systems. Yeast systems are widely used, convenient and cost-eff...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | Microbial Cell Factories |
Online Access: | http://www.microbialcellfactories.com/content/11/1/53 |